Cyclo Therapeutics Correlations

CYTHW Stock

USD 0.14 0.04 22.22%

The current 90-days correlation between Cyclo Therapeutics and Radcom is 0.04 (i.e., Significant diversification). The correlation of Cyclo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cyclo Therapeutics Correlation With Market

Good diversification

The correlation between Cyclo Therapeutics and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For more information on how to buy Cyclo Stock please use our How to Invest in Cyclo Therapeutics guide.

Moving against Cyclo Stock

0.65	MTEM	Molecular Templates	Pair Corr
0.54	TPST	Tempest Therapeutics	Pair Corr
0.45	ME	23Andme Holding	Pair Corr
0.45	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.45	NKTX	Nkarta Inc	Pair Corr
0.33	IPSC	Century Therapeutics	Pair Corr
0.53	EC	Ecopetrol SA ADR	Pair Corr
0.46	TLK	Telkom Indonesia Tbk	Pair Corr
0.46	KO	Coca Cola Aggressive Push	Pair Corr
0.4	HYMTF	Hyundai Motor	Pair Corr
0.4	PG	Procter Gamble	Pair Corr
0.35	SHG	Shinhan Financial	Pair Corr

Related Correlations Analysis

	RDCM	BCE	ASUR	GOCO	QBEIF	EIG	PLMR
RDCM		-0.75	0.17	0.68	0.32	0.7	0.49	RDCM
BCE	-0.75		-0.1	-0.78	-0.44	-0.89	-0.51	BCE
ASUR	0.17	-0.1		0.46	0.39	0.17	-0.09	ASUR
GOCO	0.68	-0.78	0.46		0.5	0.65	0.13	GOCO
QBEIF	0.32	-0.44	0.39	0.5		0.41	0.26	QBEIF
EIG	0.7	-0.89	0.17	0.65	0.41		0.67	EIG
PLMR	0.49	-0.51	-0.09	0.13	0.26	0.67		PLMR
	RDCM	BCE	ASUR	GOCO	QBEIF	EIG	PLMR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

EIG	+ 0.7	RDCM
GOCO	+ 0.68	RDCM
PLMR	+ 0.67	EIG
EIG	+ 0.65	GOCO
QBEIF	+ 0.5	GOCO
PLMR	+ 0.49	RDCM

High negative correlations

EIG	- 0.89	BCE
GOCO	- 0.78	BCE
BCE	- 0.75	RDCM
PLMR	- 0.51	BCE
QBEIF	- 0.44	BCE
ASUR	- 0.1	BCE

Risk-Adjusted Indicators

There is a big difference between Cyclo Stock performing well and Cyclo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cyclo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RDCM	2.29	0.31	0.07	1.01	3.12	(2.44)	5.40	(5.38)	19.90
BCE	0.86	(0.37)	0.00	(2.85)	0.00	0.00	1.53	(1.83)	12.47
ASUR	1.84	0.08	0.04	0.15	2.91	(2.06)	5.27	(3.76)	19.48
GOCO	3.79	0.71	0.16	1.42	3.66	(4.64)	8.03	(6.88)	37.83
QBEIF	0.86	0.21	0.00	(0.49)	0.00	0.00	4.48	0.00	15.68
EIG	1.03	0.08	0.09	0.17	1.02	(1.18)	2.46	(1.95)	11.24
PLMR	1.60	0.09	0.07	0.16	1.81	(1.89)	4.52	(3.01)	12.94

Cyclo Therapeutics Corporate Management

Michael Lisjak	Global Development	Profile
George Fails	Ex Mang	Profile
Jeffrey Tate	Chief COO	Profile
Scott Fine	CEO Director	Profile
Lori McKenna	Global Advocacy	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC